Lung Cancer

Long-term Outcomes and Emerging Combinations With Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A GameOn! Challenge

Long-term Outcomes and Emerging Combinations With Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A GameOn! Challenge

Treatment of advanced non-small cell lung cancer (NSCLC) has rapidly evolv…

Expiration Date: 9/29/2023

Max Credits: 0.5

View Activity

Expert Connect: Insights Into the Management of Treatment-Experienced Patients With SCLC

Expert Connect: Insights Into the Management of Treatment-Experienced Patients With SCLC

Small-cell lung cancer (SCLC) accounts for approximately 15% of lung cance…

Expiration Date: 12/20/2021

Max Credits: 0

View Activity

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Managing NSCLC and SCLC in the Community: What You Need to Know About the Latest Advances in Targeted Therapies and Immune Checkpoint Inhibitors

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 2/26/2021

Max Credits: 0

View Activity

2019 Texas Oncology Clinical Educational Symposium

2019 Texas Oncology Clinical Educational Symposium

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 6/27/2020

Max Credits: 0

View Activity

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 5/12/2020

Max Credits: 0

View Activity

EGFR T790M-Mutated NSCLC: The Latest on Testing and Treating

EGFR T790M-Mutated NSCLC: The Latest on Testing and Treating

Lung cancer is a leading cause of cancer death worldwide. The American Can…

Expiration Date: 5/10/2019

Max Credits: 0

View Activity

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

The integration of immune checkpoint inhibitors into treatment strategies …

Expiration Date: 2/23/2018

Max Credits: 0

View Activity

Immuno-oncology Forum: Focus on Non-small Cell Lung Cancer

Immuno-oncology Forum: Focus on Non-small Cell Lung Cancer

Lung cancer accounts for 27% of all cancer deaths in the United States, ma…

Expiration Date: 10/26/2017

Max Credits: 0

View Activity

NSCLC Treatment on Target: Examining New Evidence and Advances

NSCLC Treatment on Target: Examining New Evidence and Advances

Globally, lung cancer is the leading cause of cancer-related deaths. Eight…

Expiration Date: 12/15/2016

Max Credits: 0

View Activity

NSCLC Treatment on Target: Examining New Evidence and Advances

NSCLC Treatment on Target: Examining New Evidence and Advances

Globally, lung cancer is the leading cause of cancer-related deaths. Eight…

Expiration Date: 11/9/2016

Max Credits: 0

View Activity